Related references
Note: Only part of the references are listed.Pelvic node dissection in prostate cancer: extended, limited, or not at all?
Matthew Eric Hyndman et al.
CURRENT OPINION IN UROLOGY (2010)
Dose Escalation in Prostate Radiotherapy up to 82 Gy Using Simultaneous Integrated Boost Direct Comparison of Acute and Late Toxicity with 3D-CRT 74 Gy and IMRT 78 Gy
Martin Dolezel et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy
Robert W. Ross et al.
CLINICAL IMAGING (2009)
Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients
G. Holl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Positive Lymph Nodes at Lymphadenectomy for Prostate Cancer: Where Do We Set the Tiller?
George N. Thalmann
EUROPEAN UROLOGY (2009)
Pelvic Lymph Node Dissection in Prostate Cancer
Alberto Briganti et al.
EUROPEAN UROLOGY (2009)
PELVIC LYMPH NODE TOPOGRAPHY FOR RADIOTHERAPY TREATMENT PLANNING FROM FERUMOXTRAN-10 CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING
Robert Dinniwell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
HIGHER-THAN-CONVENTIONAL RADIATION DOSES IN LOCALIZED PROSTATE CANCER TREATMENT: A META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
Gustavo Arruda Viani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
WHOLE PELVIC RADIOTHERAPY VERSUS PROSTATE ONLY RADIOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED OR AGGRESSIVE PROSTATE ADENOCARCINOMA
Ayal A. Aizer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
PREDICTING THE RISK OF PELVIC NODE INVOLVEMENT AMONG MEN WITH PROSTATE CANCER IN THE CONTEMPORARY ERA
Paul L. Nguyen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Dreidimensionale konformale risikoadaptierte Radiotherapie des lokalisierten Prostatakarzinoms mit moderater Dosiseskalation von 70 auf 74 Gy. 5-Jahres-Resultate der prospektiven osterreichisch-deutschen Phase-II-Multicenterstudie
Gregor Goldner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
IMRT of Prostate Cancer A Comparison of Fluence Optimization with Sequential Segmentation and Direct Step-and-Shoot Optimization
Marius Treutwein et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
Moderate Dose Escalation in Three-Dimensional Conformal Localized Prostate Cancer Radiotherapy Single-institutional Experience in 398 Patients Comparing 66Gy versus 70Gy versus 74Gy
Gregor Goldner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
Pelvic lymph node irradiation for prostate cancer: Who, why, and when?
Dian Wang et al.
SEMINARS IN RADIATION ONCOLOGY (2008)
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01
Pascal Pommier et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
Colleen A. Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique
Ute Ganswindt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients
Jelle O. Barentsz et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer
Alice Wang-Chesebro et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The role of whole pelvic radiotherapy in locally advanced prostate cancer
Piet Dirix et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy
HA Shih et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy
JB Ashman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
MG Harisinghani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation therapy oncology group 9413
M Roach et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients
MJ Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis
A Heidenreich et al.
JOURNAL OF UROLOGY (2002)